In the sixties, psychedelics were all the rage and this continued, up until the year 1995, when Jerry Garcia, a figure who was at the forefront of the U.S. psychedelic culture, died. The consumption of LSD, which is a psychedelic substance, decreased in the whole country.
Today, drugs such as psilocybin (an active ingredient found in magic mushrooms) and LSD are now being studied for the potential benefits they might possess that could help mankind. They are also being used to help treat anxiety as well as depression. It has been reported that some individuals are using the drugs daily, as they claim it boosts creativity and energy.
This November, the state of Oregon will hold a vote to legalize psilocybin-assisted therapy in the whole state. In a study published in July in the International journal of Drug and Alcohol Dependence, the report shows that the use of LSD has increased by 56% between 2015-2018, with an enormous growth of 223% recorded among individuals aged 35-49. This is being referred to as the ‘psychedelic renaissance’, which is rather peculiar seeing as it seems not to be about restoring the hippie sixties psychedelic culture.
The recent studies on America’s growth in the use of LSD show that the drug is mostly used by individuals who seek an escape from reality as well as a therapeutic treatment. Despite its new shiny rebranded pharmacological model, many still equate it to the LSD use of the 60’s decade. Psychedelics were seen as a medium to promote a feeling of togetherness as well as individuals being more pro-social. Additionally, they provided a mental space for people to come up with alternative ideas.
Following the coronavirus outbreak, it is reported that the use of drugs and in particular, LSD has almost tripled. In another recent study that was carried out in New York City’s dance scene, findings showed growth in the use of LSD, resounding the late-sixties rock concerts and outdoor music festivals era, as well as other hedonistic practices which were all mobilized by LSD.
Regardless, the benefits seem to outweigh the disadvantages, with psychedelics helping ease depression and anxiety, increase people’s empathy and expand the mind’s capacity to think of some better world.
Any individual that finds the use of psychedelics to be a nuisance or its assimilation into the pharmaceutical field, should take comfort in the numerous studies published that suggest that the countercultural spirit of psychedelia appears to be alive and well.
This increased interest in the therapeutic uses of psychedelics may be the reason why companies like Pure Extract Technologies Inc. are investing heavily into psychedelic research and development.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.